Results

Total Results: 71 records

Showing results for "corp".

1. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
   October 27, 2009 - OCULIGHT GL SE 8/28/1996 IRIDEX CORP. … OCULIGHT SL/SLX SE 5/3/2002 IRIDEX CORP. IRIDEX WIRELESS FOOTSWITCH SE 11/14/2006 IRIDEX CORP. … LIGHTLAS 561 Registered n/a LIGHTMED CORP. LIGHTLAS 532 Registered n/a LIGHTMED CORP. … LIGHTLAS 810 Registered n/a LIGHTMED CORP. LIGHTLAS SELECTOR DEUX Registered n/a LIGHTMED CORP. … ZIESS ENDOPROBE SE 7/9/1992 CAVITRON CORP. SLIT LAMP ATTACHMENT SE 9/16/1980 CAVITRON CORP.

2. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
   December 23, 2009 - S2LO SE 8/5/1998 OKADA CORP. … CORP. POCKET OPHTHALMOSCOPE GH SE 11/27/1984 DESIGN MED. CORP. … MULTIPLE Registered n/a RAY VISION INTL CORP. … n/a TOPCON CORP. 3D OCT-2000; OPTICAL COHERENCE TOMOGRAPHY SYSTEM Registered n/a TOPCON CORP. 3D OCT … ACCUPEN Registered n/a AMERICAN OPTICAL CORP.

3. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
   December 23, 2009 - S2LO SE 8/5/1998 OKADA CORP. … CORP. POCKET OPHTHALMOSCOPE GH SE 11/27/1984 DESIGN MED. CORP. … MULTIPLE Registered n/a RAY VISION INTL CORP. … n/a TOPCON CORP. 3D OCT-2000; OPTICAL COHERENCE TOMOGRAPHY SYSTEM Registered n/a TOPCON CORP. 3D OCT … ACCUPEN Registered n/a AMERICAN OPTICAL CORP.

4. Disposition of Comment Report for Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
   May 20, 2013 - Public Comment: SmartPill Corp Executive Summary Safety profile and addressing comment that there … Public Comment: SmartPill Corp Executive Summary a. … Public Comment: SmartPill Corp Executive Summary Table A. … Public Comment: SmartPill Corp Introduction b. … Public Comment: SmartPill Corp Introduction c.

5. PULMONARY with "Discussions" in Exec Summary (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
   January 01, 2012 - line catheter or by subcutaneous injection every 3 days (Remodulin ® injection, United Therapeutics Corp … line catheter or by subcutaneous injection every 3 days (Remodulin ® injection, United Therapeutics Corp … Research Triangle Park (NC): United Therapeutics Corp.; 2011 Feb [accessed 2012 May 10]. [33 p].

6. Tonsillectomy Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
   February 10, 2016 -  Tonsil  &  Adenoid  Sponges   Ritmed  Inc.   6/3/1983   K830264   Myle's  Guillotine   Kelleher  Corp … .   8/30/1982   K822274   Tonsil  Dissectors   Kelleher  Corp.   8/24/1982   K822187   Tonsil  Snares …   Kelleher  Corp.   8/24/1982   K822188   Tonsil  Scissors  7   Conphar  Inc.   5/28/1982   K821292 … 2015 Tonsil  Sponges   Stan-­Pak  Ent.   2/4/1982   K820095   Sterile  Tonsil  Sponges   Medspec  Corp

7. Urinary-Incontinence-Treatment Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
   September 30, 2010 - Insight Medical, Bolton, MA) FemSoft urethral insert FemSoft1 Urethral Insert (Rochester Medical Corp … (NICMS) Developed by the investigators Pessaries Mylex Products Inc., Chicago, IL, and Mentor Corp … Chicago, and PelvX/DesChutes Medical Products, Bend, Ore The Reliance Urinary Control Insert UroMed Corp … occlusive device (FemAssist*) Insight Medical, Boston, MA Reliance urinary control insert Uromed Corp

8. Diabetes Mellitus (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
   January 01, 2012 - A noninjectable insulin in development, Oral-lyn™ (Generex Biotechnology Corp., Toronto, Ontario, … formulation of human insulin delivered as a buccal spray, called Oral-lyn™ (Generex Biotechnology Corp … and 80 mcg/day groups but were not statistically different between those two groups. 56 ALZA Corp … Duros technology. 52,57,57,57-59 Intarcia licensed exclusive rights for use of Duros from ALZA Corp … Generex Biotechnology Corp.

9. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
   January 01, 2005 - Binomial exact confidence intervals for proportions were calculated using Stata v9.1 (Stata Corp, College

10. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
    January 01, 2007 - Binomial exact confidence intervals for proportions were calculated using Stata v9.1 (Stata Corp, College

11. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
    March 01, 2012 - A noninjectable insulin in development, Oral-lyn™ (Generex Biotechnology Corp., Toronto, Ontario, … formulation of human insulin delivered as a buccal spray, called Oral-lyn™ (Generex Biotechnology Corp … and 80 mcg/day groups, but were not statistically different between those two groups. 55 Alza Corp … Duros technology. 8,8,8,51,56,57 Intarcia licensed exclusive rights for use of Duros from Alza Corp … Generex Biotechnology Corp.

12. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
    October 22, 2012 - All dosages As needed Inhaled (nasal, oral) Approved Asmanex Mometasone Schering-Plough Corp … 900+ more brands Pseudoephedrine Topical decongestants Afrin Oxymetazoline Schering-Plough Corp … GlaxoSmithKline All dosages As needed Inhaled (nasal, oral) Approved Dulera, Foradil Formoterol Schering Corp

13. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
    December 16, 2011 - a structured, electronic form and enter data into a Microsoft Excel™ 2007 spreadsheet (Microsoft Corp … Manager version 5.0.22 (The Cochrane Collaboration, Copenhagen, Denmark) and Stata version 7.0 (Stata Corp

14. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
    January 31, 2013 - FDA approved Excimer laser atherectomy Laser ablative atherectomy Spectranetics Corp FDA approved … CLiRpath Laser ablative atherectomy Spectranetics Corp FDA approved ThromCat Thrombectomy … Thrombectomy Spectranetics Corp FDA approved Percutaneous Thrombolytic Device Thrombolysis catheter … approved Exxcel Vascular graft Maquet Cardiovascular LLC FDA approved Vectra Vascular graft Thoratec Corp

15. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
    April 01, 2012 - System AHRQ Priority Area 13 – Pulmonary Disease Asthmatx, Inc., acquired by Boston Scientific Corp … energy using the Alair® Bronchial Thermoplasty System (Asthmatx, Inc., acquired by Boston Scientific Corp

16. Antipsychotics-Children Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - will be extracted using a standardized form and entered into a Microsoft Excel™ database (Microsoft Corp … Manager version 5.0.22 (The Cochrane Collaboration, Copenhagen, Denmark) and Stata version 7.0 (Stata Corp

17. Cer-243-Prehospital-Airway-Management-Appendix-F-1 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
    January 01, 2016 - NA McMullan, 2014 3 SGA King LT (King Systems, Inc., Noblesville, IN) Combitube (Kendall-Sheridan Corp … NA McMullan, 2014 3 SGA King LT (King Systems, Inc., Noblesville, IN) Combitube (Kendall-Sheridan Corp … NA McMullan, 2014 3 SGA King LT (King Systems, Inc., Noblesville, IN) Combitube (Kendall-Sheridan Corp … NA McMullan, 2014 3 SGA King LT (King Systems, Inc., Noblesville, IN) Combitube (Kendall-Sheridan Corp … NA McMullan, 2014 3 SGA King LT (King Systems, Inc., Noblesville, IN) Combitube (Kendall-Sheridan Corp

18. C- Evidence-based Practice Center Technical Brief Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
    August 05, 2010 - Statistical analyses will be conducted using Stata version 11.1/SE (Stata Corp., College Station, TX

19. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - A noninjectable insulin in development, Oral-lyn™ (Generex Biotechnology Corp., Toronto, Ontario, … formulation of human insulin delivered as a buccal spray, called Oral-lyn ™ (Generex Biotechnology Corp … months; the drug was also reported to be stable when stored for up to 3 years at 40°C. 61 ALZA Corp … Generex Biotechnology Corp.

20. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
    January 30, 2013 - Varies Intravenous (continuous infusion) Approved Remodulin Treprostinil United Therapeutics Corp … 10 mg/ml Varies Intravenous; Subcutaneous Approved Tyvaso Treprostinil United Therapeutics Corp